Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ADMELOG 100 UNIT

INSULIN LISPRO : 100 UNIT · DIN 02469901 · SANOFI-AVENTIS CANADA INC

Health Canada status: MARKETED

What is ADMELOG?

ADMELOG 100 UNIT contains INSULIN LISPRO : 100 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02469901, held by SANOFI-AVENTIS CANADA INC, supplied as SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 22-Nov-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is ADMELOG used for?

ADMELOG (insulin lispro injection) is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. ADMELOG insulin is also indicated for the initial stabilization of diabetes mellitus. ADMELOG (insulin lispro injection) is a short acting insulin analogue and is for use in conjunction with a longer acting insulin, except when used in a subcutaneous insulin infusion pump.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02469901
Brand nameADMELOG
Generic / active ingredientINSULIN LISPRO : 100 UNIT
ManufacturerSANOFI-AVENTIS CANADA INC
Strength100 UNIT
Dosage formSOLUTION
Route of administrationSUBCUTANEOUS
ScheduleSchedule D
ATC codeA10AB04 INSULIN LISPRO
AHFS class68:20.08
BiosimilarYes
Health Canada statusMARKETED
Status date22-Nov-2019
Original market date2019-11-22 00:00:00

How is it stored and handled?

null

How is it supplied?

Vial, 10 mL, 1 vial/box; Cartridge, 3 mL, 5 cartridges/box; Disposable SoloSTAR, 3 mL prefilled pen, 5 pens/box

What can be used instead?

Other Canadian products sharing ATC code A10AB04 INSULIN LISPRO. 8 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ADMELOG100 UNITSOLUTIONSANOFI-AVENTIS CANADA INCMARKETEDDIN 02469898
ADMELOG SOLOSTAR100 UNITSOLUTIONSANOFI-AVENTIS CANADA INCMARKETEDDIN 02469871
HUMALOG100 UNITSOLUTIONELI LILLY CANADA INCMARKETEDDIN 02229704
HUMALOG100 UNITSOLUTIONELI LILLY CANADA INCMARKETEDDIN 02470152
HUMALOG (CARTRIDGE)100 UNITSOLUTIONELI LILLY CANADA INCMARKETEDDIN 02229705
HUMALOG (KWIKPEN)100 UNITSOLUTIONELI LILLY CANADA INCMARKETEDDIN 02403412
HUMALOG 200 UNITS/ML KWIKPEN200 UNITSOLUTIONELI LILLY CANADA INCMARKETEDDIN 02439611
HUMALOG PEN100 UNITLIQUIDELI LILLY CANADA INCCANCELLED POST MARKETDIN 02241283
LIPRELOG100 UNITSOLUTIONELI LILLY CANADA INCCANCELLED PRE MARKETDIN 02513374
LIPRELOG100 UNITSOLUTIONELI LILLY CANADA INCCANCELLED PRE MARKETDIN 02513331

Who else supplies INSULIN LISPRO worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. INSULIN LISPRO appears in 441 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ADMELOG

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02469901. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.